These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 17412760
21. NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. Macheiner D, Heller G, Kappel S, Bichler C, Stättner S, Ziegler B, Kandioler D, Wrba F, Schulte-Hermann R, Zöchbauer-Müller S, Grasl-Kraupp B. J Hepatol; 2006 Jul; 45(1):81-9. PubMed ID: 16516329 [Abstract] [Full Text] [Related]
22. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M. Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357 [Abstract] [Full Text] [Related]
23. The assessment of methylated BASP1 and SRD5A2 levels in the detection of early hepatocellular carcinoma. Tsunedomi R, Ogawa Y, Iizuka N, Sakamoto K, Tamesa T, Moribe T, Oka M. Int J Oncol; 2010 Jan; 36(1):205-12. PubMed ID: 19956849 [Abstract] [Full Text] [Related]
24. Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Jin J, You H, Yu B, Deng Y, Tang N, Yao G, Shu H, Yang S, Qin W. Biochem Biophys Res Commun; 2009 Jan 30; 379(1):86-91. PubMed ID: 19100240 [Abstract] [Full Text] [Related]
25. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma. Huang ZH, Hu Y, Hua D, Wu YY, Song MX, Cheng ZH. Exp Mol Pathol; 2011 Dec 30; 91(3):702-7. PubMed ID: 21884695 [Abstract] [Full Text] [Related]
28. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma. Ko E, Kim Y, Kim SJ, Joh JW, Song S, Park CK, Park J, Kim DH. Cancer Epidemiol Biomarkers Prev; 2008 Sep 30; 17(9):2260-7. PubMed ID: 18723830 [Abstract] [Full Text] [Related]
34. [Analysis of DNA methylation pattern of c-myc oncogene in hepatocellular carcinoma]. Xiao W, Liu W, Lu Y. Zhonghua Yi Xue Za Zhi; 1996 Jul 30; 76(7):501-4. PubMed ID: 9275498 [Abstract] [Full Text] [Related]
36. RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients. Araújo OC, Rosa AS, Fernandes A, Niel C, Villela-Nogueira CA, Pannain V, Araujo NM. PLoS One; 2016 Jul 30; 11(4):e0153796. PubMed ID: 27078152 [Abstract] [Full Text] [Related]
38. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver. von Delius S, Lersch C, Schulte-Frohlinde E, Fend F, Dobritz M, Schmid RM, Eckel F. Z Gastroenterol; 2006 Jan 30; 44(1):39-42. PubMed ID: 16397838 [Abstract] [Full Text] [Related]
39. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest. Gho JW, Ip WK, Chan KY, Law PT, Lai PB, Wong N. Cancer Res; 2008 Aug 15; 68(16):6743-51. PubMed ID: 18701499 [Abstract] [Full Text] [Related]
40. [Epigenetic inactivation of microRNA genes in mammary carcinoma]. Lehmann U, Hasemeier B, Römermann D, Müller M, Länger F, Kreipe H. Verh Dtsch Ges Pathol; 2007 Aug 15; 91():214-20. PubMed ID: 18314617 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]